Your browser doesn't support javascript.
Brazilian Dialysis Survey 2020.
Nerbass, Fabiana B; Lima, Helbert do Nascimento; Thomé, Fernando Saldanha; Vieira Neto, Osvaldo Merege; Lugon, Jocemir Ronaldo; Sesso, Ricardo.
  • Nerbass FB; Fundação Pró-Rim, Joinville, SC, Brasil.
  • Lima HDN; Universidade da Região de Joinville, Joinville, SC, Brasil.
  • Thomé FS; Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
  • Vieira Neto OM; Universidade de São Paulo, Ribeirão Preto, SP, Brasil.
  • Lugon JR; Universidade Federal Fluminense, Niterói, RJ, Brasil.
  • Sesso R; Universidade Federal de São Paulo, São Paulo, SP, Brasil.
J Bras Nefrol ; 44(3): 349-357, 2022.
Article in English, Portuguese | MEDLINE | ID: covidwho-2300842
ABSTRACT

INTRODUCTION:

National data on chronic dialysis treatment are essential to support the development of health policies aimed at improving the treatment for thousands of people.

OBJECTIVE:

To report epidemiological data from the 2020 Brazilian Dialysis Survey, sponsored by the Brazilian Society of Nephrology.

METHODS:

A survey was carried out in Brazilian chronic dialysis centers using an online questionnaire for the year, covering clinical and epidemiological aspects of patients in a chronic dialysis program, data on dialysis therapy, characteristics of dialysis units and the impact of the COVID-19 pandemic.

RESULTS:

235 (28%) of the centers responded to the questionnaire. In July 2020, the estimated total number of patients on dialysis was 144,779. The estimated prevalence and incidence rates of patients per million population (pmp) were 684 and 209, respectively. Of the prevalent patients, 92.6% were on hemodialysis (HD) and 7.4% were on peritoneal dialysis (PD); 23% were on the transplant waiting list. A central venous catheter was used by a quarter of patients on HD. The incidence rate of confirmed COVID-19 between February and July 2020 was 684/10,000 dialysis patients, and the lethality rate was 25.7%. The estimated overall mortality and COVID-19 crude annual mortality rates were 24.5 and 4.2%, respectively.

CONCLUSION:

The absolute number of patients on chronic dialysis and prevalence rate continued to increase. The low use of PD as dialysis therapy was maintained and the use of long-term catheters for HD increased. The COVID-19 pandemic contributed to the increase in the overall mortality rate.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Kidney Failure, Chronic Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: South America / Brazil Language: English / Portuguese Journal: J Bras Nefrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: 2175-8239-JBN-2021-0198

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Kidney Failure, Chronic Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: South America / Brazil Language: English / Portuguese Journal: J Bras Nefrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: 2175-8239-JBN-2021-0198